Cargando…
From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study
The last decade has seen the adverse outcome pathways (AOP) framework become one of the most powerful tools in chemical risk assessment, but the development of new AOPs remains a slow and manually intensive process. Here, we present a faster approach for AOP generation, based on manually curated cau...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915909/ https://www.ncbi.nlm.nih.gov/pubmed/35295214 http://dx.doi.org/10.3389/ftox.2022.815754 |
_version_ | 1784668164179623936 |
---|---|
author | Ramšak, Živa Modic, Vid Li, Roman A. vom Berg, Colette Zupanic, Anze |
author_facet | Ramšak, Živa Modic, Vid Li, Roman A. vom Berg, Colette Zupanic, Anze |
author_sort | Ramšak, Živa |
collection | PubMed |
description | The last decade has seen the adverse outcome pathways (AOP) framework become one of the most powerful tools in chemical risk assessment, but the development of new AOPs remains a slow and manually intensive process. Here, we present a faster approach for AOP generation, based on manually curated causal toxicological networks. As a case study, we took a recently published zebrafish developmental neurotoxicity network, which contains causally connected molecular events leading to neuropathologies, and developed two new adverse outcome pathways: Inhibition of Fyna (Src family tyrosine kinase A) leading to increased mortality via decreased eye size (AOP 399 on AOP-Wiki) and GSK3beta (Glycogen synthase kinase 3 beta) inactivation leading to increased mortality via defects in developing inner ear (AOP 410). The approach consists of an automatic separation of the toxicological network into candidate AOPs, filtering the AOPs according to available evidence and length as well as manual development of new AOPs and weight-of-evidence evaluation. The semiautomatic approach described here provides a new opportunity for fast and straightforward AOP development based on large network resources. |
format | Online Article Text |
id | pubmed-8915909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89159092022-03-15 From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study Ramšak, Živa Modic, Vid Li, Roman A. vom Berg, Colette Zupanic, Anze Front Toxicol Toxicology The last decade has seen the adverse outcome pathways (AOP) framework become one of the most powerful tools in chemical risk assessment, but the development of new AOPs remains a slow and manually intensive process. Here, we present a faster approach for AOP generation, based on manually curated causal toxicological networks. As a case study, we took a recently published zebrafish developmental neurotoxicity network, which contains causally connected molecular events leading to neuropathologies, and developed two new adverse outcome pathways: Inhibition of Fyna (Src family tyrosine kinase A) leading to increased mortality via decreased eye size (AOP 399 on AOP-Wiki) and GSK3beta (Glycogen synthase kinase 3 beta) inactivation leading to increased mortality via defects in developing inner ear (AOP 410). The approach consists of an automatic separation of the toxicological network into candidate AOPs, filtering the AOPs according to available evidence and length as well as manual development of new AOPs and weight-of-evidence evaluation. The semiautomatic approach described here provides a new opportunity for fast and straightforward AOP development based on large network resources. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8915909/ /pubmed/35295214 http://dx.doi.org/10.3389/ftox.2022.815754 Text en Copyright © 2022 Ramšak, Modic, Li, vom Berg and Zupanic. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Toxicology Ramšak, Živa Modic, Vid Li, Roman A. vom Berg, Colette Zupanic, Anze From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title | From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title_full | From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title_fullStr | From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title_full_unstemmed | From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title_short | From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study |
title_sort | from causal networks to adverse outcome pathways: a developmental neurotoxicity case study |
topic | Toxicology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915909/ https://www.ncbi.nlm.nih.gov/pubmed/35295214 http://dx.doi.org/10.3389/ftox.2022.815754 |
work_keys_str_mv | AT ramsakziva fromcausalnetworkstoadverseoutcomepathwaysadevelopmentalneurotoxicitycasestudy AT modicvid fromcausalnetworkstoadverseoutcomepathwaysadevelopmentalneurotoxicitycasestudy AT liromana fromcausalnetworkstoadverseoutcomepathwaysadevelopmentalneurotoxicitycasestudy AT vombergcolette fromcausalnetworkstoadverseoutcomepathwaysadevelopmentalneurotoxicitycasestudy AT zupanicanze fromcausalnetworkstoadverseoutcomepathwaysadevelopmentalneurotoxicitycasestudy |